Impact on autonomy of biweekly docetaxel as first-line chemotherapy (CT) regimen in elderly patients with metastatic breast cancer (MBC) – A FNCLCC Gerico Group Phase II multicentre trial

Authors :: Jean Genève
F. Gouttenoire
S. Gourgou-Bourgade
S. Delaloge
Emmanuel Blot
Véronique Girre
Frédérique Rousseau
Source :: Critical Reviews in Oncology/Hematology. 68:S45
Publication Year :: 2008
Publisher :: Elsevier BV, 2008.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Hematology
medicine.disease
Metastatic breast cancer
Regimen
Docetaxel
Internal medicine
Medicine
First line chemotherapy
business
medicine.drug

Full Text Access

Tools